gallium-ga-68-dotatate and Cauda-Equina-Syndrome

gallium-ga-68-dotatate has been researched along with Cauda-Equina-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for gallium-ga-68-dotatate and Cauda-Equina-Syndrome

Article	Year
Detection of Cauda Equine Syndrome With 18F-FDG PET/CT and Leptomeningeal Metastasis by 68Ga-DOTATATE in the Same Patient With Large Cell Neuroendocrine Carcinoma of Lung. Clinical nuclear medicine, 2021, 06-01, Volume: 46, Issue:6 Leptomeningeal metastasis is the metastatic spread of the disease to leptomeninges from solid tumors such as breast, lung cancer, and melanoma. Cauda equine syndrome is a neurological condition caused by compression of the cauda equine. The incidence of large cell neuroendocrine carcinoma in resected lung cancers appears to be 2.1% and 3.5%. The incidence of clinically diagnosed leptomeningeal metastasis in patients with solid tumors is approximately 5%. Here, we present cauda equine syndrome caused by the metastasis of large cell neuroendocrine carcinoma detected by 18F-FDG PET/CT and also 68Ga-DOTATATE PET/CT. Topics: Cauda Equina Syndrome; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Meningeal Neoplasms; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography	2021

Article

Year

Detection of Cauda Equine Syndrome With 18F-FDG PET/CT and Leptomeningeal Metastasis by 68Ga-DOTATATE in the Same Patient With Large Cell Neuroendocrine Carcinoma of Lung.

Clinical nuclear medicine, 2021, 06-01, Volume: 46, Issue:6

Leptomeningeal metastasis is the metastatic spread of the disease to leptomeninges from solid tumors such as breast, lung cancer, and melanoma. Cauda equine syndrome is a neurological condition caused by compression of the cauda equine. The incidence of large cell neuroendocrine carcinoma in resected lung cancers appears to be 2.1% and 3.5%. The incidence of clinically diagnosed leptomeningeal metastasis in patients with solid tumors is approximately 5%. Here, we present cauda equine syndrome caused by the metastasis of large cell neuroendocrine carcinoma detected by 18F-FDG PET/CT and also 68Ga-DOTATATE PET/CT.

Topics: Cauda Equina Syndrome; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Meningeal Neoplasms; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography

2021